Entering text into the input field will update the search result below

Lumos Pharma announces new buyback program

  • Lumos Pharma (NASDAQ:LUMO) announced Tuesday that it has received Board's approval to repurchase up to $3M of company's common shares.
  • As of June 30, 2022, the biotech firm had approximately $79.5M of cash, cash equivalents, and marketable securities. About 8.4M shares of the company are outstanding as

Recommended For You

More Trending News

About LUMO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
LUMO--
Lumos Pharma, Inc.